A functional polymorphism in Pre-miR-146a is associated with susceptibility to gastric cancer in a Chinese population. 2012

Fengying Zhou, and Haixia Zhu, and Dewei Luo, and Meilin Wang, and Xiao Dong, and Yan Hong, and Bo Lu, and Yan Zhou, and Jianwei Zhou, and Zhengdong Zhang, and Weida Gong
Department of Surgery, Yixing Cancer Hospital, Yixing, China.

MicroRNAs play an important role in regulating gene expression at the post-transcriptional level and are involved in numerous physiological processes. Aberrant expression of MicroRNAs is considered to participate in occurrence and progression of human cancers. A G>C polymorphism, rs2910164, which is located in the sequence of miR-146a precursor, could alter mature miR-146a expression and has been suggested to influence cancer risk. The present study was aimed to investigate whether this polymorphism has effects on susceptibility to gastric cancer in the Chinese population. We genotyped the miR-146a rs2910164 polymorphism using the TaqMan method in a two-stage case-control study comprising a total of 1686 gastric cancer patients and 1895 cancer-free subjects. The logistic regression was used to assess the genetic associations with gastric cancer risk. We found a significant association between rs2910164 polymorphism and increased gastric cancer risk [p = 0.038, odds ratio (OR) = 1.26, 95% confidence interval (CI) = 1.01-1.56; GG vs. CC/CG]. Similar results were observed in a follow-up replication study. Combined data from the two studies generated a more significant association [p = 0.001, OR = 1.27, 95% CI = 1.10-1.46; GG vs. CC/CG]. Besides, the increased risk associated with the rs2910164GG genotype was more evident in younger subjects (OR = 1.51, 95% CI = 1.25-1.81) rather than in older subjects. Our results suggest that the rs2910164 polymorphism in the sequence of miR-146a precursor may influence the susceptibility to gastric cancer in our Chinese population.

UI MeSH Term Description Entries
D008297 Male Males
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012322 RNA Precursors RNA transcripts of the DNA that are in some unfinished stage of post-transcriptional processing (RNA PROCESSING, POST-TRANSCRIPTIONAL) required for function. RNA precursors may undergo several steps of RNA SPLICING during which the phosphodiester bonds at exon-intron boundaries are cleaved and the introns are excised. Consequently a new bond is formed between the ends of the exons. Resulting mature RNAs can then be used; for example, mature mRNA (RNA, MESSENGER) is used as a template for protein production. Precursor RNA,Primary RNA Transcript,RNA, Messenger, Precursors,RNA, Ribosomal, Precursors,RNA, Small Nuclear, Precursors,RNA, Transfer, Precursors,Pre-mRNA,Pre-rRNA,Pre-snRNA,Pre-tRNA,Primary Transcript, RNA,RNA Precursor,mRNA Precursor,rRNA Precursor,snRNA Precursor,tRNA Precursor,Pre mRNA,Pre rRNA,Pre snRNA,Pre tRNA,Precursor, RNA,Precursor, mRNA,Precursor, rRNA,Precursor, snRNA,Precursor, tRNA,Precursors, RNA,RNA Primary Transcript,RNA Transcript, Primary,RNA, Precursor,Transcript, Primary RNA,Transcript, RNA Primary
D013274 Stomach Neoplasms Tumors or cancer of the STOMACH. Cancer of Stomach,Gastric Cancer,Gastric Neoplasms,Stomach Cancer,Cancer of the Stomach,Gastric Cancer, Familial Diffuse,Neoplasms, Gastric,Neoplasms, Stomach,Cancer, Gastric,Cancer, Stomach,Cancers, Gastric,Cancers, Stomach,Gastric Cancers,Gastric Neoplasm,Neoplasm, Gastric,Neoplasm, Stomach,Stomach Cancers,Stomach Neoplasm
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D044466 Asian People Persons having origins in any of the Asian racial groups of the Far East, Southeast Asia, or the Indian subcontinent including, for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam. Note that OMB category ASIAN is available for United States population groups. Race and ethnicity terms, as used in the federal government, are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies. Asian Continental Ancestry Group,Asian Person,Asiatic Race,Mongoloid Race,Asian Peoples,Asian Persons,Asiatic Races,Mongoloid Races,People, Asian,Person, Asian,Race, Asiatic,Race, Mongoloid
D020022 Genetic Predisposition to Disease A latent susceptibility to disease at the genetic level, which may be activated under certain conditions. Genetic Predisposition,Genetic Susceptibility,Predisposition, Genetic,Susceptibility, Genetic,Genetic Predispositions,Genetic Susceptibilities,Predispositions, Genetic,Susceptibilities, Genetic
D020641 Polymorphism, Single Nucleotide A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population. SNPs,Single Nucleotide Polymorphism,Nucleotide Polymorphism, Single,Nucleotide Polymorphisms, Single,Polymorphisms, Single Nucleotide,Single Nucleotide Polymorphisms

Related Publications

Fengying Zhou, and Haixia Zhu, and Dewei Luo, and Meilin Wang, and Xiao Dong, and Yan Hong, and Bo Lu, and Yan Zhou, and Jianwei Zhou, and Zhengdong Zhang, and Weida Gong
July 2011, Gynecologic oncology,
Fengying Zhou, and Haixia Zhu, and Dewei Luo, and Meilin Wang, and Xiao Dong, and Yan Hong, and Bo Lu, and Yan Zhou, and Jianwei Zhou, and Zhengdong Zhang, and Weida Gong
July 2010, World journal of gastroenterology,
Fengying Zhou, and Haixia Zhu, and Dewei Luo, and Meilin Wang, and Xiao Dong, and Yan Hong, and Bo Lu, and Yan Zhou, and Jianwei Zhou, and Zhengdong Zhang, and Weida Gong
October 2016, British journal of biomedical science,
Fengying Zhou, and Haixia Zhu, and Dewei Luo, and Meilin Wang, and Xiao Dong, and Yan Hong, and Bo Lu, and Yan Zhou, and Jianwei Zhou, and Zhengdong Zhang, and Weida Gong
April 2010, The Prostate,
Fengying Zhou, and Haixia Zhu, and Dewei Luo, and Meilin Wang, and Xiao Dong, and Yan Hong, and Bo Lu, and Yan Zhou, and Jianwei Zhou, and Zhengdong Zhang, and Weida Gong
April 2016, Genetics and molecular research : GMR,
Fengying Zhou, and Haixia Zhu, and Dewei Luo, and Meilin Wang, and Xiao Dong, and Yan Hong, and Bo Lu, and Yan Zhou, and Jianwei Zhou, and Zhengdong Zhang, and Weida Gong
October 2014, Medical oncology (Northwood, London, England),
Fengying Zhou, and Haixia Zhu, and Dewei Luo, and Meilin Wang, and Xiao Dong, and Yan Hong, and Bo Lu, and Yan Zhou, and Jianwei Zhou, and Zhengdong Zhang, and Weida Gong
January 2014, Mediators of inflammation,
Fengying Zhou, and Haixia Zhu, and Dewei Luo, and Meilin Wang, and Xiao Dong, and Yan Hong, and Bo Lu, and Yan Zhou, and Jianwei Zhou, and Zhengdong Zhang, and Weida Gong
September 2012, Medical oncology (Northwood, London, England),
Fengying Zhou, and Haixia Zhu, and Dewei Luo, and Meilin Wang, and Xiao Dong, and Yan Hong, and Bo Lu, and Yan Zhou, and Jianwei Zhou, and Zhengdong Zhang, and Weida Gong
March 2017, European journal of cancer care,
Fengying Zhou, and Haixia Zhu, and Dewei Luo, and Meilin Wang, and Xiao Dong, and Yan Hong, and Bo Lu, and Yan Zhou, and Jianwei Zhou, and Zhengdong Zhang, and Weida Gong
April 2018, Cancer medicine,
Copied contents to your clipboard!